Back to Assenagon Asset Management S.A. Assenagon Asset Management S.A.

ABTABT
Showing 9 of 31 quarters

Position history for Assenagon Asset Management S.A.Assenagon Asset Management S.A.'s holdings in ABBOTT LABORATORIES

Yes. Assenagon Asset Management holds 5,187,488 shares of ABT (Abbott Laboratories), worth $512.7M, as of its Q3 2026 13F filing. It increased the position by 1,968,916 shares (+61.2%) from Q2 2026. Assenagon Asset Management has held ABT since Q1 2020, across 27 quarterly 13F filings. ABT is 0.5% of Assenagon Asset Management's reported 13F portfolio.

Current Value

$512.7M

Current Shares

5.2M

Total Value Change

+$253M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
5.2M
+61.2%
$512.7M0.5%$98.23
54
2026-Q2
Decreased
3.2M
-27.3%
$292.1M0.4%$89.55
0
2026-Q1
Increased
4.4M
+303.0%
$454.8M0.7%$100.69
71
2025-Q4
Increased
1.1M
+333.4%
$137.7M0.2%$122.25
58
2025-Q3
Decreased
253,593
-86.7%
$34M0.0%$130.11
0
2025-Q2
Increased
1.9M
+1.8%
$259.7M0.4%$131.53
37
2025-Q1
Increased
1.9M
+7.3%
$248.9M0.4%$127.69
40
2024-Q4
Decreased
1.7M
-23.3%
$197.7M0.3%$108.31
0
2024-Q3
Decreased
2.3M
-5.2%
$259.7M0.5%$108.66
0

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used